IBEX Ltd. (NASDAQ: IBEX) was founded in 2017, formerly known as IBEX Holdings Ltd, registered in Bermuda, headquartered in Washington State, USA, with 22,537 full-time employees. It is a technology-based customer lifecycle experience (“CLX”) solution Is a leading end-to-end provider that provides solutions to help world-renowned brands interact with customers more effectively.
IBEX Ltd. (IBEX):
IBEX Holdings provides customers with a comprehensive portfolio of solutions through its integrated CLX platform to provide customers with optimized user acquisition, maintenance, expansion and experience.
From past experience, these solutions are usually provided in an independent manner, and are often used as key solutions in the customer’s life cycle. However, as customer needs become more challenging, complex and competitive, these solutions are increasingly converging. In addition, due to the popularity of instant feedback channels such as social media, customer expectations and behaviors are undergoing tremendous changes, forcing companies to pay more attention to understanding consumer needs.
To achieve this transformation, IBEX Holdings has designed a differentiated digital, omni-channel, customer-centric solution that can seamlessly manage interactions at all stages of the customer life cycle. IBEX Holdings uses advanced technology and proprietary analysis techniques, combined with the company’s global contact and delivery center layout, and business process outsourcing (“BPO”) expertise to protect and enhance customers’ brands and grow businesses. IBEX’s global delivery network combines onshore, nearshore and offshore BPO functions, enabling it to flexibly deploy solutions to meet the unique needs of customers. The company manages approximately 55 million interactions with consumers every year through omni-channel methods, including: voice, network, chat and email. Although traditional voice channels still account for the vast majority of IBEX Holdings’ revenue, digital channels (web, chat, email) are becoming relatively important. For all IBEX solutions, companies are increasingly using automation, machine learning and analysis to improve and optimize their capabilities.
IBEX Ltd. (IBEX) investment:
IBEX Ltd. (NASDAQ: IBEX) 2/23/2018 originally submitted IPO prospectus, scheduled for 3/29/2018 to iQIYI NASDAQ IPO the same day, the issue price of $ 14.00-16.00, issued 400 million shares , Raised funds not exceeding 73.6 million US dollars, stock code: IBEX. Also listed on the same day: Homology Medicines , iQiyi and Unum Therapeutics , but they were delayed for some reason.
It was finally listed on NASDAQ on 8/7/2020 IPO. The planned issue price was $20.00-$22.00, the actual issue price was $19, 4.8 million shares were issued, and 91.2 million US dollars were raised. Citigroup/ RBC Capital Markets/ Baird underwriting, SunTrust Robinson Humphrey/ Piper Sandler jointly.